{
  "id": 18585896,
  "title": "Mangoceuticals board and preferred shareholder approve new Series D preferred stock",
  "url": "https://urgent.news/2026/11/06/mangoceuticals-board-and-preferred-shareholder-approve-new-series-d",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-06T22:52:36.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/sec-filings/mangoceuticals-board-and-preferred-shareholder-approve-new-series-d-preferred-stock-93CH-5009364"
  },
  "original_language": "en",
  "account": null,
  "summary": "Mangoceuticals, Inc. (MGRX) has announced the approval of its board and the sole holder of its Series B Convertible Preferred Stock for the creation of a new class of 8% Series D Convertible Cumulative Preferred Stock. This move comes as the company's stock trades at $0.19 with a market capitalization of $4.26 million, down 89% over the past year. The newly approved Series D Preferred Stock would allow the company to offer up to 1,000,000 shares at $10.00 per share through a Regulation A offering, despite the company's current liquidity challenges indicated by a ratio of 0.18.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}